Breaking News Instant updates and real-time market news.

SSNLF

Samsung

, SIMO

Silicon Motion

$44.24

-0.61 (-1.36%)

04:55
01/05/17
01/05
04:55
01/05/17
04:55

Nomura holds events at CES 2017

Nomura Events at CES 2017 will be held in Las Vegas on January 4-5.

SSNLF

Samsung

SIMO

Silicon Motion

$44.24

-0.61 (-1.36%)

SMIC

Smith Investment Company

LRCX

Lam Research

$107.32

0.06 (0.06%)

MU

Micron

$22.36

-0.19 (-0.84%)

TSLA

Tesla

$226.99

10 (4.61%)

SNE

Sony

$28.58

0.29 (1.03%)

TM

Toyota

$121.19

2.64 (2.23%)

  • 05

    Jan

  • 10

    Jan

SSNLF Samsung

11/01/16
ADAM
11/01/16
NO CHANGE
Target $13
ADAM
Buy
DSP Group long-term thesis remains on track, says Canaccord
Canaccord analyst Matthew Ramsay noted DSP Group (DSPG) reported strong September results driven by record revenue in new product categories. The analyst noted new design wins and said the company is well positioned to yield a return to solid sales growth at higher margins and has the financial position to secure business with large customers. Ramsay reiterated his Buy rating but lowered his price target to $13 from $14 based on the Samsung (SSNLF) Note 7 cancellation.
11/01/16
BMUR
11/01/16
NO CHANGE
Target $25
BMUR
Buy
Integrated Device continues to push through rough patch, says Brean Capital
Brean Capital analyst Mike Burton noted Integrated Device (IDTI) reported relatively in-line Q1 results and gave mixed guidance as the company is being impacted by Samsung's (SSNLF) Note 7 recall. The analyst believes the company is working through its rough patch and executing well on the margin and cost side of its business model. Burton reiterated his Buy rating and raised his price target to $25 from $23 on Integrated Device shares.
10/26/16
NEED
10/26/16
NO CHANGE
Target $150
NEED
Strong Buy
Needham recommends buying Apple on Pokemon Go, Samsung upside
Following Apple's (AAPL) Q4 results, Needham analyst Laura Martin notes that iPhone revenue rose driven in part by Samsung's (SSNLF) Galaxy Note 7 imploding in September and estimates $10B-$20B of brand value transfers to Apple during the next adoption cycle owing to Samsung's poor handling of the replacement, recall and ultimate discontinuation of the Note 7. Of the company's extra services revenue quarter over quarter, the analyst's channel checks indicate that Niantic and Nintendo's (NTDOY) Pokemon Go represented much of the growth. Martin reiterates a Strong Buy and $150 price target on Apple's shares.
10/18/16
UBSW
10/18/16
NO CHANGE
Target $127
UBSW
Buy
Apple near-term outlook improved, says UBS
UBS analyst Steven Milunovich believe Apple's (AAPL) Q4 guidance could have upside due to an extra week in the quarter and checks that show iPhone 7 demand is a bit better than the iPhone 6s. The analyst also noted the Samsung (SSNLF) Note 7 problem remains a wild card, but believes it should help Apple's retention rate. Milunovich said the current Apple share price reflects a gradual erosion of its installed base and the amount people are willing to spend with Apple, which he believes is conservative. Milunovich reiterated his Buy rating and $127 price target on Apple shares.
SIMO Silicon Motion
$44.24

-0.61 (-1.36%)

12/05/16
LOOP
12/05/16
INITIATION
Target $55
LOOP
Buy
Silicon Motion initiated with a Buy at Loop Capital
Loop Capital initiated Silicon Motion with a Buy rating and $55 price target.
11/03/16
BMUR
11/03/16
NO CHANGE
Target $60
BMUR
Buy
Silicon Motion inexpensive for above-average growth, says Brean Capital
Brean Capital analyst Mike Burton updated his model for Silicon Motion after last week's Q3 results. The analyst admitted the company's ultra-high growth is moderating but shares remain inexpensive for above average growth. Burton believes the company is being conservative with guidance for the mobile end market but it has the opportunities available to grow at least in-line with its end markets. Burton maintained his Buy rating on Silicon Motion shares.
01/03/17
PACS
01/03/17
INITIATION
Target $54
PACS
Overweight
Silicon Motion resumed with an Overweight at Pacific Crest
Pacific Crest analyst Michael McConnell resumed coverage of Silicon Motion with an Overweight rating and $54 price target. The analyst believes the company is likely to gain further market share in the controller market.
12/22/16
CHLM
12/22/16
NO CHANGE
CHLM
Micron report positive for Silicon Motion, says Craig-Hallum
Craig-Hallum analyst Tony Stoss said Micron's (MU) positive report highlighted strong demand it its SSD business. Stoss believes this is a positive for Silicon Motion (SIMO) as Micron uses its controller in their SSDs. Stoss rates Silicon Motion a Buy.
SMIC Smith Investment Company

LRCX Lam Research
$107.32

0.06 (0.06%)

11/22/16
DADA
11/22/16
NO CHANGE
DADA
Lam Research poised to outperform, says DA Davidson
DA Davidson analyst Thomas Diffely says that Lam Research will continue to outperform, driven by its leverage to the fastest growing segments of the strong semiconductor equipment space. The analyst thinks that the company made "a compelling case" for the sector's strong outlook at its analyst meeting last week. He continues to expect the company to benefit from the proliferation of 3D NAND, and he reiterates a $125 price target and a Buy rating on the shares.
12/19/16
GSCO
12/19/16
UPGRADE
GSCO
Conviction Buy
Lam Research upgraded to Conviction Buy from Neutral at Goldman
Goldman analyst Toshiya Hari upgraded Lam Research to Conviction Buy with a $125 price target. The analyst is bullish on Lam's product positioning given its strong share in deposition and etch, sees upside to Street estimates, and believes improvements in its logic business will result in a higher multiple.
10/25/16
GSCO
10/25/16
INITIATION
Target $104
GSCO
Neutral
Lam Research reinstated with a Neutral at Goldman
Goldman analyst Toshiya Hari reinstated coverage on Lam Research with a Neutral and a $104 price target.
11/29/16
SBSH
11/29/16
NO CHANGE
Target $123
SBSH
Buy
Lam Research price target raised to $123 from $114 at Citi
Citi analyst Atif Malik raised his price target for Lam Research to $123 after increasing his expectations for 3D NAND shipments in the first half of 2017. Lam's position in 3D NAND and the large growth opportunity it represents for the company justifies a multiple towards the high end of historical range, Malik tells investors in a research note. He keeps a Buy rating on the shares.
MU Micron
$22.36

-0.19 (-0.84%)

12/22/16
12/22/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Micron (MU) was upgraded to Buy from Hold at Cross Research, to Buy from Underperform at Needham, and to Buy from Hold at Summit Redstone. 2. Sunoco (SUN) upgraded to Outperform from Market Perform at FBR Capital with analyst Robert Balsamo saying the credit facility amendments announced reduce the need for a distribution cut. The analyst has a $32 price target for the shares. 3. National Instruments (NATI) upgraded to Outperform from Neutral at Baird with analyst Richard Eastman saying he sees the potential for accelerating revenue growth over the next few years combined with more determined focus to deliver operating leverage. 4. Merus (MRUS) upgraded to Buy from Neutral at Citi with analyst Yigal Nochomovitz saying the Incyte (INCY) collaboration deal has "very favorable" terms. 5. Sucampo (SCMP) upgraded to Buy from Neutral at Mizuho with the firm citing the sell-off in shares post the $260M convertible raise. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/22/16
CRSS
12/22/16
UPGRADE
CRSS
Buy
Micron upgraded to Buy from Hold at Cross Research
12/22/16
EVER
12/22/16
NO CHANGE
Target $30
EVER
Buy
Micron price target raised to $30 from $25 at Evercore ISI
TSLA Tesla
$226.99

10 (4.61%)

01/04/17
01/04/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Guggenheim analyst Robert Cihra initiated Apple (AAPL) with a Buy rating and $140 price target, stating that while iPhones have slowed to now being cyclical he thinks the company can stay a step ahead of commoditization by maintaining its lead in software with iOS and processing with the Ax chip. 2. JPMorgan analyst Cory Kasimov started Global Blood Therapeutics (GBT) with an Overweight rating and $25 price target. If successful, the company's GBT440 would be the first new sickle cell disease therapy approved in two decades, Kasimov tells investors. 3. Needham analyst Laura Martin initiated Priceline (PCLN) with a Buy and a $1,800 price target due to its market lading position, history of execution, and OTA ecosystem competitive advantages. 4. Canaccord analyst Richard Close initiated Teladoc (TDOC) with a Buy rating and $24 price target. Close said Teladoc is the first mover, industry leader and the only publicly traded telemedicine company. 5. Guggenheim analyst Robert Cihra initiated Tesla (TSLA) with a Buy rating and $280 price target, as he acknowledges it faces a number of risks but also has "nearly open-ended growth disrupting the trillion-dollar auto market." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/04/17
GUGG
01/04/17
INITIATION
Target $280
GUGG
Buy
Tesla initiated with a Buy at Guggenheim
Guggenheim analyst Robert Cihra initiated Tesla with a Buy rating and $280 price target, as he acknowledges it faces a number of risks but also has "nearly open-ended growth disrupting the trillion-dollar auto market."
12/30/16
BARD
12/30/16
NO CHANGE
Target $338
BARD
Outperform
Tesla named a Best Pick for 2017 at Baird
Baird analyst Ben Kallo named Tesla a Best Pick for 2017 as he believes the ramp of Tesla Energy and Model 3 production could exceed expectations and are not yet reflected in the share price. He also believes the Q4 delivery number will not be an overhang and he sees the shares hitting new highs in 2017. Kallo reiterated his Outperform rating and $338 price target on Tesla shares.
12/28/16
PIPR
12/28/16
NO CHANGE
PIPR
Piper lays out top Auto and Truck picks into 2017
Piper Jaffray analyst Alexander Potter ranked his auto- and truck-related stocks in order of conviction heading into 2017. His top three names are General Motors (GM), Delphi (DLPH) and Mobileye (MBLY). Mobileye offers the most "compelling upside potential" at almost 70%, but also the most risk, Potter tells investors in a research note on the Autos, Trucks, and Advanced Mobility space. As such, the stock sits third behind GM and Delphi in order of preference. After a strong showing in 2016, the analyst thinks most of the truck stocks will struggle to outperform in 2017. He calls Allison Transmission (ALSN) a notable Underweight.
SNE Sony
$28.58

0.29 (1.03%)

07/06/16
07/06/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. TASER (TASR) upgraded to Buy from Neutral at CL King with analyst George Godfrey citing strong organic growth, a leading position in body cameras, low international market exposure, accelerating earnings growth and margin expansion, and weapons segment opportunity growth. 2. Sony (SNE) upgraded to Buy from Hold at Deutsche Bank with analyst Hiroshi Taguchi saying the company's shipment growth will likely exceed expectations. 3. U.S. Steel (X) upgraded to Hold from Sell at Deutsche Bank with analyst Jorge Beristain citing his firm's improved steel price outlook as well as the company's' balance sheet refinancing. 4. SunPower (SPWR) upgraded to Buy from Neutral at UBS with Julien Dumoulin-Smith citing valuation, a strong technology track record and product development, early indications that utility scale margins are proving more intact versus expectations, and a solid balance sheet. 5. Royal Gold (RGLD) upgraded to Outperform from Market Perform at Raymond James and to Buy from Neutral at Dundee. Raymond James analyst Phil Russo upgraded Royal Gold to Outperform and increased his price target to $85 from $72 following amended terms at Mt Milligan with new operator Centerra Gold. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/09/16
PIPR
09/09/16
NO CHANGE
PIPR
August NPD video game software sales rose 1%, says Piper Jaffray
Piper Jaffray analyst Michael Olson says August NPD video game software sales were up 1% year-over-year, driven by Sony (SNE) publishing No Man's Sky and Electronic Arts' (EA) Madden NFL 17. The data are most positive for Activision Blizzard (ATVI), which continued to benefit from sell-through of incremental title Overwatch, Olson tells investors in a research note. He believes the monthly numbers are largely irrelevant for Take-Two (TTWO), since NBA 2K17 is due out in September, and GameStop (GME), since the company announced October quarter guidance at the end of August.
08/18/16
PIPR
08/18/16
NO CHANGE
Target $41
PIPR
Overweight
Piper Jaffray bullish on GameStop ahead of quarterly results
With GameStop (GME) scheduled to report results next week, Piper Jaffray analyst Michael Olson sees potential for slight July quarter upside driven by May launches of Sony's (SNE) Uncharted 4 and Activision's (ATVI) Overwatch. Further, the analyst expects largely unchanged fiscal year guide, and anticipates improving software growth in the second half of the year, driven by easier comps and a next-generation console footprint that he believes is over 60M units. Olson reiterates an Overweight rating and $41 price target on GameStop's shares.
08/24/16
STFL
08/24/16
NO CHANGE
STFL
Ambarella Q2 revenue guidance could beat expectations, says Stifel
Stifel analyst Kevin Cassidy says he is "cautiously optimistic" that Ambarella's (AMBA) Q2 revenue guidance will come in above expectations. The company was worried about whether Sony (SNE) would be able to meet demand for its sensors used in high end surveillance cameras, but recent checks show that it was able to do so, the analyst stated. Additionally, Ambarella's Q3 guidance should project year-over-year growth, given GoPro's (GPRO) initial Hero 5 builds, according to Cassidy. He keeps an $86 price target and Buy rating on Ambarella.
TM Toyota
$121.19

2.64 (2.23%)

08/25/16
SBSH
08/25/16
DOWNGRADE
SBSH
Neutral
Toyota downgraded to Neutral from Buy at Citi
Citi analyst Arifumi Yoshida downgraded Toyota to Neutral citing recent yen strength versus European currencies that will negatively impact the premium Lexus segment.
09/05/16
GSCO
09/05/16
DOWNGRADE
GSCO
Neutral
Toyota downgraded to Neutral from Buy at Goldman
Goldman Sachs downgraded Toyota (TM) to Neutral and kept a Buy rating on Honda (HMC).
12/15/16
MACQ
12/15/16
DOWNGRADE
MACQ
Neutral
Toyota downgraded to Neutral from Outperform at Macquarie
12/15/16
12/15/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Valeant (VRX) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst David Risinger saying the thesis that management would stabilize the business and execute asset sales has been wrong. 2. General Mills (GIS) downgraded to Sector Perform from Outperform at RBC Capital with analyst David Palmer saying he believes that accelerating U.S. volume declines which occurred over the last three months will limit the company's EPS growth. 3. Toyota (TM) downgraded to Neutral from Outperform at Macquarie. 4. Zimmer Biomet (ZBH) downgraded to Sell from Neutral at UBS with analyst Matt Miksic citing a survey of 139 U.S. orthopedic surgeons, which he said shows evidence of the share gain potential of Stryker's (SYK) MAKO in the U.S. total knee market. 5. Brinker (EAT) downgraded to Underperform from Market Perform at BMO Capital with analyst Andrew Strelzik citing valuation and the company's relatively weak margin outlook. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

21:00
05/26/17
05/26
21:00
05/26/17
21:00
General news
Breaking General news story  »

San Francisco Federal…

20:00
05/26/17
05/26
20:00
05/26/17
20:00
General news
Breaking General news story  »

San Francisco Federal…

JUNO

Juno Therapeutics

$23.30

-2.22 (-8.70%)

18:11
05/26/17
05/26
18:11
05/26/17
18:11
Hot Stocks
Juno Therapeutics director acquires 20,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

UNH

UnitedHealth

$177.50

-0.55 (-0.31%)

18:06
05/26/17
05/26
18:06
05/26/17
18:06
Hot Stocks
UnitedHealth's OptumHealth awarded $200.5M government contract »

UnitedHealth's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

VEC

Vectrus

$29.62

0.02 (0.07%)

17:56
05/26/17
05/26
17:56
05/26/17
17:56
Hot Stocks
Vectrus Systems awarded $212.03M modification to government contract »

Vectrus Systems was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMMY

Imprimis

$3.34

-0.06 (-1.76%)

17:52
05/26/17
05/26
17:52
05/26/17
17:52
Syndicate
Breaking Syndicate news story on Imprimis »

Imprimis files $75M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRCP

IRSA Propiedades Comerciales

$43.58

-0.33 (-0.75%)

17:51
05/26/17
05/26
17:51
05/26/17
17:51
Syndicate
Breaking Syndicate news story on IRSA Propiedades Comerciales »

IRSA Propiedades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSKE

Daseke

$9.79

-0.11 (-1.11%)

17:44
05/26/17
05/26
17:44
05/26/17
17:44
Syndicate
Breaking Syndicate news story on Daseke »

Daseke files $300M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECYT

Endocyte

$2.47

0.02 (0.82%)

, RNN

Rexahn

$4.04

0.09 (2.28%)

17:35
05/26/17
05/26
17:35
05/26/17
17:35
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Endocyte (ECYT),…

ECYT

Endocyte

$2.47

0.02 (0.82%)

RNN

Rexahn

$4.04

0.09 (2.28%)

TGTX

TG Therapeutics

$12.05

0.15 (1.26%)

SGMO

Sangamo

$7.25

-0.55 (-7.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 22

    Jun

ECYT

Endocyte

$2.47

0.02 (0.82%)

17:33
05/26/17
05/26
17:33
05/26/17
17:33
Hot Stocks
Endocyte to announce updated data on EC1456, EC1169 at ASCO »

Endocyte announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

PEP

PepsiCo

$117.91

0.38 (0.32%)

17:30
05/26/17
05/26
17:30
05/26/17
17:30
Periodicals
PepsiCo in talks to acquire Vita Coco owner All Market, Reuters reports »

PepsiCo is in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCOV

Brightcove

$6.25

0.25 (4.17%)

17:25
05/26/17
05/26
17:25
05/26/17
17:25
Hot Stocks
Breaking Hot Stocks news story on Brightcove »

ESW Capital reports 8.08%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

SHIP

Seanergy Marine

$0.69

0.001244 (0.18%)

17:19
05/26/17
05/26
17:19
05/26/17
17:19
Hot Stocks
Seanergy Marine receives Nasdaq notice »

Seanergy Maritime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$10.93

0.07 (0.64%)

, DB

Deutsche Bank

$18.46

-0.39 (-2.07%)

17:10
05/26/17
05/26
17:10
05/26/17
17:10
General news
S&P advances to end week at record as Fed signals no rush to normalize policy »

The S&P 500 (SPX)…

F

Ford

$10.93

0.07 (0.64%)

DB

Deutsche Bank

$18.46

-0.39 (-2.07%)

BBY

Best Buy

$58.97

-2.28 (-3.72%)

HPQ

HP Inc.

$18.47

0.1 (0.54%)

BX

Blackstone

$32.58

0.11 (0.34%)

NOK

Nokia

$6.38

-0.02 (-0.31%)

AAPL

Apple

$153.61

-0.26 (-0.17%)

GM

General Motors

$33.07

0.47 (1.44%)

HUN

Huntsman

$24.75

-0.11 (-0.44%)

BF.A

Brown-Forman, also tag with BFA, BFB

$52.49

-0.21 (-0.40%)

BF.B

Brown-Forman, also tag with BFA, BFB

$51.73

0.13 (0.25%)

STZ

Constellation Brands

$180.93

0.79 (0.44%)

LOW

Lowe's

$80.91

-0.42 (-0.52%)

TIF

Tiffany

$86.18

0.36 (0.42%)

SHLD

Sears

$7.78

-0.7 (-8.25%)

SIG

Signet Jewelers

$49.31

-0.99 (-1.97%)

COST

Costco

$177.86

3.13 (1.79%)

ANF

Abercrombie & Fitch

$13.22

-0.83 (-5.91%)

AEO

American Eagle

$11.50

0.08 (0.70%)

EXPR

Express

$7.85

0.03 (0.38%)

TTWO

Take-Two

$77.07

-1.46 (-1.86%)

AZO

AutoZone

$615.62

8.28 (1.36%)

DSW

DSW

$16.73

-0.06 (-0.36%)

INTU

Intuit

$138.56

0.2 (0.14%)

PBYI

Puma Biotechnology

$79.75

1.7 (2.18%)

CHS

Chico's

$9.37

-0.39 (-4.00%)

SPLS

Staples

$8.98

-0.08 (-0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 31

    May

  • 31

    May

  • 01

    Jun

  • 01

    Jun

  • 01

    Jun

  • 02

    Jun

  • 06

    Jun

  • 06

    Jun

  • 06

    Jun

  • 07

    Jun

  • 12

    Jun

  • 12

    Jun

  • 13

    Jun

  • 20

    Jun

  • 28

    Jun

  • 21

    Jul

BGNE

BeiGene

$37.42

-0.04 (-0.11%)

17:07
05/26/17
05/26
17:07
05/26/17
17:07
Syndicate
Breaking Syndicate news story on BeiGene »

BeiGene files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 06

    Jun

CGI

Celadon Group

17:06
05/26/17
05/26
17:06
05/26/17
17:06
Hot Stocks
Breaking Hot Stocks news story on Celadon Group »

Litespeed Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRD

Crawford & Company Inc.

, CRDA

Crawford & Co.

$7.65

0.01 (0.13%)

17:05
05/26/17
05/26
17:05
05/26/17
17:05
Hot Stocks
Crawford & Company COO Robinson to leave company »

Crawford & Company…

CRD

Crawford & Company Inc.

CRDA

Crawford & Co.

$7.65

0.01 (0.13%)

CRDB

Crawford & Company

$9.08

-0.02 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEAS

SeaWorld

$18.08

-0.13 (-0.71%)

17:03
05/26/17
05/26
17:03
05/26/17
17:03
Hot Stocks
Breaking Hot Stocks news story on SeaWorld »

Hill Path Capital raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DMRC

Digimarc

$36.10

2.45 (7.28%)

17:03
05/26/17
05/26
17:03
05/26/17
17:03
Syndicate
Breaking Syndicate news story on Digimarc »

Digimarc files $100M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 06

    Sep

IPCI

Intellipharmaceutics

$1.94

-0.01 (-0.51%)

17:01
05/26/17
05/26
17:01
05/26/17
17:01
Syndicate
Breaking Syndicate news story on Intellipharmaceutics »

Intellipharmaceutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

GWR

Genesee & Wyoming

$66.47

0.91 (1.39%)

16:57
05/26/17
05/26
16:57
05/26/17
16:57
Hot Stocks
Genesee & Wyoming CEO Hellmann named chairman of the board »

Genesee & Wyoming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZG

Paramount Gold Nevada

$1.61

0.02 (1.26%)

16:54
05/26/17
05/26
16:54
05/26/17
16:54
Syndicate
Breaking Syndicate news story on Paramount Gold Nevada »

Paramount Gold Nevada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMO

Sangamo

$7.25

-0.55 (-7.05%)

16:53
05/26/17
05/26
16:53
05/26/17
16:53
Syndicate
Breaking Syndicate news story on Sangamo »

Sangamo files $200M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

TGTX

TG Therapeutics

$12.05

0.15 (1.26%)

16:49
05/26/17
05/26
16:49
05/26/17
16:49
Syndicate
Breaking Syndicate news story on TG Therapeutics »

TG Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 22

    Jun

AVXL

Anavex

$5.88

-0.06 (-1.01%)

16:49
05/26/17
05/26
16:49
05/26/17
16:49
Syndicate
Breaking Syndicate news story on Anavex »

Anavex files to sell 5M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.